Delivery Order SPE2DB20D1109-SPE2DB24FP33S

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.13 firm fixed-price delivery order is for the supply of 4,566,254,939 units of the hydrocodone-acetaminophen 10-325 mg drug product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,901.60 delivery order contract is for the supply of HYDROCODONE-ACETAMN 7.5-325/15 473ML, a pain management medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,731.52 Firm Fixed Price Delivery Order contract is for the supply of 4565272230 - HYDROCODONE-ACETAMN 7.5-325/15 473ML, with a period of performance through July 29, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.46 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product "HYDROCODONE-CHLORPHEN ER SUSP 115ML". The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,559.48, is a delivery order for the supply of HYDROCODONE-ACETAMN 7.5-325/15 473ML, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the...
This federal contract award, valued at $1,453.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567487914 - HYDROCODONE-ACETAMN 7.5-325/15 473ML, a pharmaceutical product, with a performance period ending on March 7, 2025. The award is a delivery order contract with a firm fixed price pricing type. It is not designated as a set-aside contract....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,037.51, is for the supply of Hydrocodone-Acetaminophen 7.5-325/15 473ML, a prescription pain medication. This delivery order was issued under an existing Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,661.20, is for the delivery of hydrocodone-acetaminophen 7.5-325 mg/15 ml medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 3, 2025. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,265.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the Defense Logistics Agency Troop Support Medical's Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of 4566325436 units of the pharmaceutical product...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,187.34 and has a Firm Fixed Price pricing type. It covers the supply of 4567355386 - HYDROCODONE/ACETAMINOPHEN TAB 10/325, with a completion date of February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP33S
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,380.02 firm fixed-price delivery order (SPE2DB20D1109|SPE2DB24FP33S) is for the supply of 473 ml of hydrocodone-acetaminophen 7.5-325 mg, with a completion date of June 14, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:34 AM